Global Neurological Biomarkers Market
Global Neurological Biomarkers Market Analysis Report 2024-2030 - CAGR of 12.8% - Increased Funding For R&D in Biomarkers to Boost Development of New Drugs
24 janv. 2024 05h40 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism),...
Moleac logo.png
Moleac’s NeuroAiD™II Improves Post-Concussion Symptoms, Quality of Life, and Mood after a Mild Traumatic Brain Injury
04 déc. 2023 22h41 HE | Moleac Pte Ltd
Promising results from the SAMURAI study show NeuroAiDTMII significantly improves post-concussion symptoms, QoL and mood post-mild traumatic brain injury.
Global Neurological Biomarkers Market
Neurological Biomarkers Research Report 2023: A Global $18.75 Billion Market by 2030 with Pipeline Analysis of Alzheimer's, Parkinson's, Multiple Sclerosis, & Autism Spectrum Disorder
14 nov. 2023 05h28 HE | Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), By Type,...
Logo.png
Traumatic Brain Injury Market to Register Sustainable Growth by 2032, Evaluates DelveInsight | Leading Companies in the Market - Life Molecular Imaging, Merz, Vasopharm, Pinteon, Omniscient Neurotechnology
18 oct. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Traumatic Brain Injury Market to Register Sustainable Growth by 2032, Evaluates DelveInsight | Leading Companies in the Market - Life Molecular...
ZyversaREV_cmyk.jpg
ZyVersa Therapeutics Announces New Peer-Reviewed Publication Reinforcing the Rationale for Inhibiting ASC Specks with IC 100 to Attenuate Spread of Inflammation into Surrounding Tissues
04 oct. 2023 07h05 HE | ZyVersa Therapeutics
Brain inflammation from traumatic injury releases proinflammatory cytokines that activate inflammasomes in the heart leading to damaging inflammation.
Aviv-Clinic Logo.png
Aviv Clinics Highlights New Literature Review Sharing the Efficacy of Hyperbaric Oxygen Therapy for Traumatic Brain Injury Patients
01 août 2023 13h24 HE | Aviv Clinics
ORLANDO, Fla., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Aviv Clinics, one of the most advanced brain clinics in the world, shares the results of a new comprehensive literature review that shows hyperbaric...
The Dan Lewis Foundation for Brain Regeneration Research Announces First Annual DLF Prize to Be Awarded Spring 2023 DENVER, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The Dan Lewis Foundation for Brain Regeneration Research (the DLF) happily announces the 2023 DLF Prize. This $15,000 prize will be awarded to an early...
ZyversaREV_cmyk.jpg
ZyVersa Therapeutics Announces New Publication in Translational Research Showing IC 100 Reduces Inflammasome Activation in Mouse Model for Alzheimer’s Disease Following Traumatic Brain Injury
23 févr. 2023 09h20 HE | ZyVersa Therapeutics
Data published in Translational Research indicate that pyroptotic release of cytokines and ASC Specks from traumatic brain injury (TBI) induces a heightened inflammasome response in Alzheimer’s...
Algernon Logo 1.png
Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints Global TBI Expert as Advisor
21 févr. 2023 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical...
ADMdx logo
ADM Diagnostics, Inc. Awarded $1.96 Million Grant From the National Institutes of Health
27 sept. 2022 09h00 HE | ADM Diagnostics Inc
NORTHBROOK, Ill., Sept. 27, 2022 (GLOBE NEWSWIRE) -- ADM Diagnostics, Inc. (ADMdx) has been awarded a two-year $1.96 million Phase II Small Business Innovation Research (SBIR) grant from the...